Previous studies have found that TXNDC5 is increased under hypoxic conditions; so, in RA, a decrease in the oxygen supply causes TXNDC5 upregulation of expression, which can be observed in affected tissues, such as fibroblast-like cells, synovial fluids and blood [10]. This evidence concerns the gene TXNDC5 and rheumatoid arthritis.